Bonesupport Holding AB

Bonesupport Holding AB specializes in developing injectable bioceramic bone graft substitutes used in orthopedics and trauma surgery. The company's proprietary technology platform, CERAMENT, fosters bone healing and regeneration, targeting applications across a variety of sectors including trauma, revision arthroplasty, and chronic osteomyelitis. CERAMENT products are designed to deliver antibiotics directly to the surgical site, minimizing the risk of infection and facilitating better patient outcomes. Bonesupport's solutions serve an essential function in addressing conditions that require bone grafting procedures, often reducing the time required for recovery and improving surgical success rates. Positioned at the intersection of healthcare and biotechnological innovation, Bonesupport Holding AB plays a vital role in advancing orthopedic treatments, ultimately enhancing the quality of life for patients worldwide. The company's ongoing research and development efforts aim to expand their product offerings and strengthen their impact on the global medical device market.